Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study

Neil Krishan Aggarwal; Kyle C. Molina; Laurel Beaty; Tellen D. Bennett; Nichole E. Carlson; David Mayer; Jennifer L. Peers; Seth Russell; Matthew K. Wynia; Adit A. Ginde

doi:10.1016/s1473-3099(23)00011-7

Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study

著者: Neil Krishan Aggarwal, Kyle C. Molina, Laurel Beaty, Tellen D. Bennett, Nichole E. Carlson, David Mayer, Jennifer L. Peers, Seth Russell, Matthew K. Wynia, Adit A. Ginde - The Lancet 2023 被引用: 145

Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study | Litlas